Dexcom Inc., one of San Diego’s biggest public medical technology firms, announced May 2 that it will acquire Nintamed, a distribution partner with presence in Germany, Switzerland and Austria.
Nintamed has served as Dexcom's exclusive distributor in these countries for six years. Financial details of the acquisition were not disclosed.
"The acquisition of Nintamed represents another step forward in our mission to improve access to our leading continous glucose monitor (CGM) technologies globally,” said Kevin Sayer, president and CEO of Dexcom, in a news release. “As we expand our international footprint, these countries represent attractive markets for Dexcom and Nintamed's team leaves us well positioned to drive continued strong growth there. Since introducing our CGM system to these countries several years ago, Nintamed, through the leadership of Rudolf Messer, has developed deep knowledge and relationships in the diabetes community. Together, I am confident we will increase the awareness of the tremendous benefits Dexcom's technologies can deliver to patients throughout this region."
Nintamed will operate closely with Dexcom's new international headquarters operations in Edinburgh, Scotland, the release said.